George Pavlakis
Hellenic Air Force
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by George Pavlakis.
Acta Oncologica | 2007
Giannis Mountzios; Meletios-Athanassios Dimopoulos; Aristotelis Bamias; George Papadopoulos; Efstathios Kastritis; Konstantinos Syrigos; George Pavlakis; Evangelos Terpos
The role of receptor activator of nuclear factor-κB ligand (RANKL)/osteoprotegerin (OPG) system, and osteopontin (OPN) was studied in patients with solid tumors metastatic to the bone in relation to the type of malignancy and the neoplastic burden to the skeleton. Levels of soluble RANKL (sRANKL), OPG and OPN were assessed in 61 patients with breast, lung and prostate cancer with newly-diagnosed metastasis to the bone, in parallel with bone resorption [C-telopeptide of type-I collagen (CTX), tartrate-resistant acid phosphatase-5b (TRACP-5b)] and bone formation markers [bone-alkaline phosphatase (bALP), osteocalcin (OC), and C-terminal propeptide of collagen type-I (CICP)]. Patients had elevated serum levels of sRANKL, OPG, OPN, TRACP-5b, and bALP, and reduced OC levels compared to controls. OPG correlated with the extent of metastatic bone burden. Patients with breast and lung cancer shared increased levels of sRANKL, OPG, and OPN whereas prostate cancer patients had elevated values of OPG and bALP only. These results suggest that patients with solid tumors metastatic to the bone have severe disruption of the sRANKL/OPG axis. Breast and lung cancer seem to exert their osteolytic action through upregulation of the sRANKL/OPG system and OPN, whereas prostate cancer seems to provoke profound elevation of OPG levels only, thus leading to increased osteoblastic activity.
Journal of Gastroenterology and Hepatology | 2005
George K Anagnostopoulos; Dimitrios Stefanou; Evdokia Arkoumani; George H. Sakorafas; George Pavlakis; Dimitrios Arvanitidis; Epameinondas Tsianos; Niki J Agnantis
Background and Aims: Bcl‐2 protein prolongs cell survival in the face of classical apoptotic stimuli, and is considered to be a suppressor of apoptosis. Bax plays a key role in apoptosis by accelerating cell death after an apoptotic stimulus. The aim of our study was to determine the roles of the Bax proapoptotic gene and the Bcl‐2 antiapoptotic gene in the carcinogenesis of gastric cancer.
European Journal of Cancer Care | 2009
George K Anagnostopoulos; George H. Sakorafas; Panagiotis Kostopoulos; George Margantinis; Stavros Tsiakos; George Pavlakis
Early gastric cancer (EGC) is defined as an adenocarcinoma confined to the gastric mucosa or submucosa, regardless of the presence of lymph node metastases. Early gastric cancer carries an excellent prognosis, with a 5-year survival rate at least 85% in most series. However, there are rare cases where distant metastases exist. Bone metastases are rare in gastric cancer; osteoblastic bone metastases are even rarer. We report a patient with EGC (mucosal) and synchronous osteosclerotic bone metastasis. To our knowledge, this is the first reported case of submucosal EGC with synchronous bone metastases. The patient was operated and he received adjuvant chemotherapy and radiotherapy. He died 18 months after gastric surgery from generalized disease.
Acta Oncologica | 2000
George H. Sakorafas; Adelais G. Tsiotou; George Pavlakis
Follow-up after primary treatment for breast cancer is a routine practice aiming at early detection and management of local recurrences and/or distant metastases of the disease or of new primaries. Breast self-examination and periodic physical examination, mammography, and pelvic examination are the most important methods in following-up these patients. The, at one time, more popular intensive routine diagnostic evaluation (including head, chest, abdominal, and pelvic computerized tomography and/or magnetic resonance imaging, liver ultrasonography, bone scans, tumor markers, etc.) is not currently considered appropriate and cost-effective. However, flexibility, based on clinical judgement, is required on the part of medical staff involved in the follow-up in order appropriately to adapt the general guidelines and meet the specific needs of the individual patients. Non-specialist or non-physician models of follow-up care have been proposed as interesting and cost-effective alternatives in the follow-up of breast cancer patients.Follow-up after primary treatment for breast cancer is a routine practice aiming at early detection and management of local recurrences and/or distant metastases of the disease or of new primaries. Breast self-examination and periodic physical examination, mammography, and pelvic examination are the most important methods in following-up these patients. The, at one time, more popular intensive routine diagnostic evaluation (including head, chest, abdominal, and pelvic computerized tomography and/or magnetic resonance imaging, liver ultrasonography, bone scans, tumor markers, etc.) is not currently considered appropriate and cost-effective. However, flexibility, based on clinical judgement, is required on the part of medical staff involved in the follow-up in order appropriately to adapt the general guidelines and meet the specific needs of the individual patients. Non-specialist or non-physician models of follow-up care have been proposed as interesting and cost-effective alternatives in the follow-up of breast cancer patients.
BMC Clinical Pathology | 2006
Giannis Mountzios; George Pavlakis; Evangelos Terpos; George H. Sakorafas; Kyriakos Revelos; Aristotelis Bamias; Nikolaos Nikolaou; Pantelis Papasavas; Jean-Charles Soria; Meletios-Athanasios Dimopoulos
BackgroundSynchronous presentation of more than one germ cell tumours of different histology in the same patient is considered to be very rare. In these cases of multiple germ cell tumours, strong theoretical and clinical data suggest an underlying common pathogenetic mechanism concerning genetic instability or abnormalities during the pluripotent embryonic differentiation and maturation of the germ cell.Case presentationA 25 year-old young man presented with an enlarging, slightly painful left cervical mass. Despite the initial disorientation of the diagnosis to a possible thyroid disorder, the patient underwent complete surgical resection of the mass revealing mediastinal choriocarcinoma. Subsequent ultrasound of the scrotum indicated the presence of a small lobular node in the upper pole of the left testicle and the patient underwent radical left inguinal orchiectomy disclosing a typical seminoma. Based on these results, the patient received 4 cycles of Bleomycin, Etoposide and Platinum chemotherapy experiencing only mild toxicity and resulting in complete ongoing clinical and biochemical remission.ConclusionThe pathogenesis of concurrent germ cell tumours in the same patient remains an area of controversy. Although the genetic instability of the pluripotent germ cell offers an adequate explanation, the possibility of metastasis from the primary, less differentiated tumour to a distant location as a more mature subtype cannot be excluded. Possible development of a metastatic site of different histology and thus biological behaviour (e.g choriocarcinoma) should be anticipated. Furthermore, urologists, pathologists and medical oncologists should be meticulous in the original pathological diagnosis in these patients, since there is a significant frequency of germ cell tumours with mixed or overlapping histological elements with diverse potential of evolution and differentiation.
Neurocritical Care | 2005
George F. Tsolakidis; Panagyotis Gallis; Konstantinos Lagios; Konstantinos Hozos; George Pavlakis; George Anthopoulos
Case Report: This article describes the events preceding and following the rupture of the right common carotid artery caused by a cervical abcess. Stent grafting resulted in a good outcome.
Surgical Oncology-oxford | 2002
George H. Sakorafas; Eustathios N. Krespis; George Pavlakis
European Journal of Cancer Care | 2005
George K Anagnostopoulos; George H. Sakorafas; Panagiotis Kostopoulos; Kyriakos Grigoriadis; George Pavlakis; George Margantinis; D. Vugiouklakis; Dimitrios Arvanitidis
Mount Sinai Journal of Medicine | 2003
George H. Sakorafas; George Pavlakis; Kyriakos Grigoriadis
Mount Sinai Journal of Medicine | 2004
George Pavlakis; George H. Sakorafas; George K. Anagnostopoulos